Research Centre | Company Search | Charting | Stock Screener | Performance Tables | Financial Diary | Investing Board
Oxford Biomedica (OXB)
Share Price: 8.92p Change Today: -0.020p  Market Cap: 276.09m

OXB Overview

Oxford Biomedica is in the pharma and biotech sector and is currently trading at 8.92p per share. In the last year Oxford Biomedica's share price has ranged from 3.00p to 10.75p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

OXB Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 7.76 (10.35) (0.76)p n/a n/a n/a n/a 0.0%
31-Dec-13 5.38 (12.76) (0.79)p n/a n/a n/a n/a 0.0%
31-Dec-14 13.62 (10.80) (0.43)p n/a n/a n/a n/a 0.0%
31-Dec-15 15.91 (16.98) (0.51)p n/a n/a n/a n/a 0.0%
31-Dec-16 27.78 (20.31) (0.60)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

OXB Company Announcements

Holding(s) in Company 07-Aug-2017 09:05 RNS
Total Voting Rights 01-Aug-2017 09:19 RNS
Notice of Interim Results 25-Jul-2017 07:00 RNS

Latest OXB Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.


Price Data

Currency UK Pounds
Share Price 8.92p
Change Today -0.020p
% Change -0.22 %
Volume 1,789,231
16-Aug-17 Close 8.92p
Shares Issued 3,095.15m
Market Cap 276.09m
Year End 31-Dec-16

OXB Dividends

No dividends found

Trades for 16-Aug-2017

Time Volume / Share Price
16:35 37,909 @ 8.92p
16:29 11,019 @ 8.94p
16:29 8,102 @ 8.87p
16:27 17,000 @ 8.91p
16:19 73,261 @ 8.90p

OXB Key Personnel

CEO John Dawson
CFO Tim Watts